Market revenue in 2023 | USD 160.3 million |
Market revenue in 2030 | USD 274.3 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Short peripheral intravenous catheter (short pivcs) |
Fastest growing segment | Short Peripheral Intravenous Catheter (Short PIVCs) |
Historical data | 2017 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Short Peripheral Intravenous Catheter (Short PIVCs), Huber Needles, Midline Catheters, Peripherally Inserted Central Catheter (PICCs), Central Venous Catheter (CVCs), Dialysis Catheters, Implantable Ports |
Key market players worldwide | Teleflex Inc, BD, B. Braun, Smiths Group PLC, Cook Medical, AngioDynamics Inc, Medtronic PLC, Terumo Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vascular access devices market will help companies and investors design strategic landscapes.
Short peripheral intravenous catheter (short pivcs) was the largest segment with a revenue share of 68.18% in 2024. Horizon Databook has segmented the China vascular access devices market based on short peripheral intravenous catheter (short pivcs), huber needles, midline catheters, peripherally inserted central catheter (piccs), central venous catheter (cvcs), dialysis catheters, implantable ports covering the revenue growth of each sub-segment from 2018 to 2030.
The vascular access devices market in China is competitive, with the presence of large market competitors such as Guangdong Baihe Medical Technology, Tianck Medical, SCW MEDICATH LTD, lepu medical technology, and Prunus Medical competing for market share. These companies has established themselves as innovative brands, providing a wide range of products.
Prior to commercialization, all medical device manufacturers in China are required to register their products with the NMPA. Simplified Chinese must be used in the registration documents. Depending on the degree of regulation required to guarantee the device's effectiveness and safety, each device is given one of three regulatory classifications.
The manufacturer of medical devices is registered in China. Medical device manufacturers must select an aftersales service provider (distributor) to service and maintain the device after getting market access from NMPA. The instructions for use must include a list of the distributor.
Horizon Databook provides a detailed overview of country-level data and insights on the China vascular access devices market, including forecasts for subscribers. This country databook contains high-level insights into China vascular access devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account